Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
Recruiting · NCT06311942 · Registry updated 2024-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC. | hepatocellular carcinoma | Recruiting | Phase 4 | 2024-05-07 | NCT06311942 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chen Xiaoping | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China | Wuhan | China | 4 |